Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Serpin Pharma logo — Enhancing cell resilience: A revolutionary approach for infl...

Serpin Pharma

Enhancing cell resilience: A revolutionary approach for inflammatory diseases

Founded 2011 United States Manassas, United States 8 employees Grant Total: $400.00K Biotechnology, Health Care +1

General Information

Company Name Serpin Pharma
Founded Year 2011
Location United States Manassas, United States
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Serpin Pharma. To contact Serpin Pharma, visit serpinpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Serpin Pharma compare?

A PDF of Serpin Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Serpin Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Serpin Pharma

Serpin Pharma is a biotechnology and health care startup based in the United States, founded in 2011. The company's slogan "Enhancing cell resilience: A revolutionary approach for inflammatory diseases" reflects its core focus on developing targeted therapeutics to enhance the body’s natural immune response. By reducing inflammation and restoring immune balance, Serpin Pharma aims to address critical unmet needs in the treatment of inflammatory diseases. The startup received a significant boost with a $400.00K grant investment on 21 June 2017, with the Virginia Catalyst as the investor. This investment not only underscores the potential of Serpin Pharma's innovative approach but also demonstrates the confidence of external stakeholders in the company's vision and capabilities. This injection of capital is an opportunity for the company to propel its research and development efforts, moving closer to realizing its mission of developing impactful therapies for inflammatory diseases. In conclusion, Serpin Pharma stands at the intersection of biotechnology and healthcare, offering a promising solution to address the challenges of inflammatory diseases. With strategic investments and a focused approach, the company is poised to make meaningful contributions to the field of immune response modulation and inflammation management.

Business keywords: biotech, therapeutics, immune response, inflammatory diseases, autoimmune diseases, infectious diseases, anti-inflammatory peptides, immune modulating peptides, targeted therapeutics, cell resilience, immune balance, Northern Virginia, privately held, development stage company

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $400.00K 1
Virginia Catalyst
21 Jun 2017

Serpin Pharma Alternatives & Competitors

View All Alternatives
Serpin Pharma vs
Nuvig Therapeutics Inc.
Nuvig Therapeutics Inc. United States

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

Series A
24 employees
Biotechnology, Health Care
Serpin Pharma vs
SQZ Biotechnologies
SQZ Biotechnologies United States

Unlocking the full potential of cell therapies for patients around the world

Grant
18 employees
Biotechnology, Health and Wellness
Serpin Pharma vs
Mysthera Therapeutics
Mysthera Therapeutics Switzerland

Multilineage immune modulation. The next chapter in autoimmune diseases.

Seed
3 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Serpin Pharma

Enhancing cell resilience: A revolutionary approach for inflammatory diseases
Serpin Pharma was founded in 2011.
Serpin Pharma is headquartered in Manassas, United States.
Serpin Pharma operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biotech, therapeutics, immune response and inflammatory diseases.
Serpin Pharma has approximately 8 employees.
Serpin Pharma has completed 1 funding round, raising a total of $400.00K. The latest funding stage is Grant.
Top alternatives and competitors to Serpin Pharma include Nuvig Therapeutics Inc., SQZ Biotechnologies, Mysthera Therapeutics, Georgiamune Inc., Immunaeon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Serpin Pharma and Nuvig Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Serpin Pharma, https://bouncewatch.com/company/serpin-pharma, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes